Industry Programs are a promotional activity and are not approved for continuing education credit unless otherwise noted. The content and opinions expressed by presenters are those of the sponsor or presenter and are not supported, endorsed, or accredited by the American Thoracic Society.
Browse by Category:
Events
Clinical Evidence in Severe Asthma: A New Biologic Option for Patients with an Eosinophilic Phenotype
Innovation Theater 6
Provided by: GSK
An Overview of JASCAYD® (nerandomilast) tablets for the Clinician
Innovation Theater 7
Provided by: Boehringer Ingelheim Pharmaceuticals, Inc.
Taking Control: The Urgent Need to Identify and Address Uncontrolled Asthma
Innovation Theater 5
Provided by: AstraZeneca
Reconsidering the Diagnosis: Could it be CF?
Innovation Theater 8
Provided by: Vertex Pharmaceuticals Incorporated
An In-Depth Discussion of Biologic Clinical Trial Data in COPD
Innovation Theater 1
Provided by: Regeneron and Sanofi
Beyond the Airway: Conversations That Shape Severe Asthma Treatment Decisions
Innovation Theater 4
Provided by: GSK
Advancements in Alpha-1 Antitrypsin Deficiency (AATD): Aiming for AAT Restoration and Clinically Meaningful Endpoints
Innovation Theater 7
Provided by: Sanofi
The Duality of IL-33 in COPD: Inflammation and Mucus Dysfunction with Dr Monica Kraft, MD
Innovation Theater 5
Provided by: AstraZeneca
Evidence Expedition: An Interactive Journey Through Clinical Data For AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg)
Innovation Theater 1
Provided by: AstraZeneca
Nasal High Flow: Does One Size Fit All?
Innovation Theaters 1
Provided by: Fisher & Paykel Healthcare, Inc.
Problem-Based Learning: Type 2 Inflammation in COPD
Innovation Theater 6
Provided by: Regeneron
Starting at the Top: A Different Approach to Severe Asthma and CRSwNP
Innovation Theater 7
Provided by: Amgen/AstraZeneca
YUTREPIA® (treprostinil) inhalation powder: a prostacyclin treatment for your PH-ILD patients
Innovation Theater 5
Provided by: Liquidia Technologies
XTMAB-16 in Sarcoidosis: First-in-Patient Study Results
Innovation Theater 8
Provided by: Xentria, Inc.
Why Wait to Escalate? New Real-World Evidence Supporting the Use of Triple Therapy in Asthma
Innovation Theater 1
Provided by: GSK
Pulmonologist & Cardiologist Live: A Collaborative Approach to Cardiopulmonary Risk in COPD
Innovation Theater 8
Provided by: AstraZeneca
A Fresh Perspective on Inflammatory Diseases: Connecting Epithelial Cytokines in Severe Asthma, CRSwNP, and COPD
Innovation Theater 4
Provided by: Amgen/AstraZeneca
Advances in Autoimmune Pulmonary Alveolar Proteinosis: From Pathophysiology to Patient Experience
Innovation Theater 6
Provided by: Savara Inc.
The Missing Piece in Asthma Management: Recognizing Small Airway Disease
Innovation Theater 7
Provided by: Chiesi USA
Unmet Needs in IPF Understanding Disease Burden and Current Approaches
Innovation Theater 5
Provided by: United Therapeutics Corporation
Why Wait to Escalate? New Real-World Evidence Supporting the Use of Triple Therapy in Asthma
Innovation Theater 1
Provided by: GSK
A Collaborative Look at Clinical Outcomes of Biologic Use in Asthma and COPD
Innovation Theater 4
Provided by: Regeneron
Bronchiectasis Care With BRINSUPRI: The First Approval in NCFB
Innovation Theater 6
Provided by: Insmed
Are Your Patients at Greater Risk of COPD Exacerbations? It Is Time to Rethink Management for COPD With an Eosinophilic Phenotype
Innovation Theater 7
Provided by: GSK
Exploring Zepbound® (tirzepatide) Injection with a Clinical Expert
Innovation Theater 5
Provided by: Eli Lilly and Company
Treating PAH Are We Ready to Aim Higher?
Innovation Theater 8
Provided by: United Therapeutics Corporation
One Size Does Not Fit All: Lessons from the RENOVATE Trial on HFNC vs NIV in Acute Respiratory Failure
Innovation Theaters 1
Provided by: Fisher & Paykel Healthcare, Inc.
Pulmonary Care Without Silos: Operationalizing the AI-Powered Viz Pulmonary Suite Across the Care Continuum
Innovation Hub 3
Provided by: Viz.ai
Improving Refractory Chronic Cough Identification: Real-World Insights on the Patient Journey
Innovation Theater 8
Provided by: GSK
Unlocking Early-Stage NSCLC: A Case-Based Dialogue on Biomarker-Driven Care Across Specialties
Innovation Theater 4
Provided by: Eli Lilly and Company
Closing the Diagnostic Gap in Bronchiectasis: A Practical Approach
Innovation Theater 6
Provided by: Insmed Incorporated
Managing Asthma When Inhalers Aren’t Enough
Innovation Theater 7
Provided by: Sanofi
Decoding Inflammation in COPD: The Role of the ST2/IL-33 Pathway
Innovation Theater 5
Provided by: Genentech
One Approach, Many Patients: Addressing Eosinophilic Inflammation
Innovation Theater 1
Provided by: AstraZeneca